Phio Pharmaceuticals Corp.
PHIO
$1.09
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.37% | -68.83% | 0.88% | -10.43% | -22.44% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -50.00% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.75% | 14.96% | 142.48% | 121.57% | 18.60% |
| Change in Net Operating Assets | 44.30% | -1,958.82% | -91.15% | 145.18% | -194.24% |
| Cash from Operations | -0.80% | -92.54% | 0.29% | 17.91% | -99.22% |
| Capital Expenditure | -- | -- | 100.00% | -133.33% | -50.00% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | 100.00% | -133.33% | -50.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 504.53% | 5,030.00% | -99.56% |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 513.50% | 4,955.00% | -99.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.88% | -138.74% | 14,851.43% | 97.20% | -131.70% |